Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.

Causes of Muscular Dystrophy

What causes muscular dystrophy?

Muscular dystrophy is caused by inheriting a changed (mutated) gene. This changed gene makes it hard for the body to build and maintain healthy muscles. All kinds of muscles can be affected, including arm, leg, and breathing muscles and the heart.

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) Duchenne Muscular Dystrophy (DMD), Nonsense Mutation Dystrophinopathy,

Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD Duchenne Muscular Dystrophy (DMD),

A Study of CK-2127107 in Patients With Spinal Muscular Atrophy Muscular Dystrophy, Spinal Muscular Atrophy

Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy Duchenne Muscular Dystrophy (DMD),

Evaluate Safety and Biological Activity of ATYR1940 in Patients With Early Onset Facioscapulohumeral Muscular Dystrophy Muscular Dystrophy,

Study of Eteplirsen in DMD Patients Duchenne Muscular Dystrophy (DMD),